Factor XI concentrate (factor XI deficiency), CSL Behring

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFactor XI concentrate (factor XI deficiency), CSL Behring
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionBlood coagulation pathway activationCoagulation factor XI stimulants
TargetsCoagulation factor XI
Therapy Area/IndicationsFactor XI Deficiency
Global Approved IndicationsFactor XI Deficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryAustralia
Original Approved Date2014/07/01
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCsl Behring Llc
China Registration ClassN/A

Develop Information

Active CompaniesCsl Behring Llc
Inactive CompaniesN/A
Active IndicationsFactor XI Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeB02BD
Related LinksN/A